Ontology highlight
ABSTRACT:
SUBMITTER: Kuhn NF
PROVIDER: S-EPMC6428219 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature
Kuhn Nicholas F NF Purdon Terence J TJ van Leeuwen Dayenne G DG Lopez Andrea V AV Curran Kevin J KJ Daniyan Anthony F AF Brentjens Renier J RJ
Cancer cell 20190301 3
Chimeric antigen receptor (CAR) T cells provide great efficacy in B cell malignancies. However, improved CAR T cell therapies are still needed. Here, we engineered tumor-targeted CAR T cells to constitutively express the immune-stimulatory molecule CD40 ligand (CD40L) and explored efficacy in different mouse leukemia/lymphoma models. We observed that CD40L<sup>+</sup> CAR T cells circumvent tumor immune escape via antigen loss through CD40/CD40L-mediated cytotoxicity and induction of a sustained ...[more]